Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Doxorubicin |
gCSI, CTRPv2 | doxorubicin |
PharmacoGx | Doxorubicin |
Database | Identifier |
---|---|
Smiles: | CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl |
Inchikey: | MWWSFMDVAYGXBV-FGBJBKNOSA-N |
Pubchem: | 32874 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAPGEF5 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
mRNA | SEMA6D | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | HCG27 | gCSI | pan-cancer | AAC | -0.25 | 8e-05 |
mRNA | ZBTB3 | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
mRNA | LRRC29 | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
mRNA | CA11 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
mRNA | E4F1 | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
mRNA | TNS3 | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
mRNA | NRBF2 | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
mRNA | TAAR1 | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |